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Abstract
Background: Very few analytical approaches have been reported to resolve the variability in
microarray measurements stemming from sample heterogeneity. For example, tissue samples used
in cancer studies are usually contaminated with the surrounding or infiltrating cell types. This
heterogeneity in the sample preparation hinders further statistical analysis, significantly so if
different samples contain different proportions of these cell types. Thus, sample heterogeneity can
result in the identification of differentially expressed genes that may be unrelated to the biological
question being studied. Similarly, irrelevant gene combinations can be discovered in the case of
gene expression based classification.
Results:  We propose a computational framework for removing the effects of sample
heterogeneity by "microdissecting" microarray data in silico. The computational method provides
estimates of the expression values of the pure (non-heterogeneous) cell samples. The inversion of
the sample heterogeneity can be facilitated by providing accurate estimates of the mixing
percentages of different cell types in each measurement. For those cases where no such
information is available, we develop an optimization-based method for joint estimation of the
mixing percentages and the expression values of the pure cell samples. We also consider the
problem of selecting the correct number of cell types.
Conclusion: The efficiency of the proposed methods is illustrated by applying them to a carefully
controlled cDNA microarray data obtained from heterogeneous samples. The results demonstrate
that the methods are capable of reconstructing both the sample and cell type specific expression
values from heterogeneous mixtures and that the mixing percentages of different cell types can also
be estimated. Furthermore, a general purpose model selection method can be used to select the
correct number of cell types.
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Background
Recent developments in high-throughput genomic tech-
nologies have revolutionized the approaches aimed at
understanding biological systems and emphasized the
need for computational and systems biology research.
Microarray analysis, for instance, can provide massive
amounts of information about a biological sample by
simultaneously measuring thousands of transcript levels.
Application of such methodologies has already yielded
important molecular insight into cellular phenotypes
under various experimental conditions [1] and provided
new knowledge about the development and treatment of
human diseases, such as cancers [2-4]. During the last sev-
eral years, microarray technology has undergone contin-
ued improvement with better quality control in the
overall measurement process, ranging from hybridization
conditions to image processing techniques [5]. Neverthe-
less, to fully harness the power of the microarray technol-
ogy to study biological materials such as cancer tissues,
one has to deal with a source of measurement variability
that comes from the biological materials themselves,
which rarely consist of homogeneous cell populations.
For example, except for a few types of immune-privileged
tissues such as the brain, most solid tumor tissues contain
infiltrating lymphocytes as a result of the immune
response. Most tumor tissues also contain endothelial
cells as part of the necessary vasculature systems that pro-
vide nutrients for the tumor cells. The complexity of this
problem is that different tumor tissues contain different
proportions of these non-tumor cells. Therefore, if tumor
tissues are used without consideration of such a mixing
phenomenon, measurement of differential gene expres-
sion will certainly be confounded by the heterogeneous
cell populations. In some studies [6], pathologists care-
fully evaluated the tissues and only selected tissues with
more than a certain percentage of tumor cells. This pre-
screening step, however, results in the exclusion of many
tumor tissues for the study and contributes to the small
sample size problem in some of the studies. Alternatively,
laser capture microdissection (LCM) technology can be
used to purify the tumor cells from mixed populations [7].
This approach has been very successful in DNA-based
studies because of the relatively high stability of DNA.
However, for microarray studies, which require less stable
RNA, LCM has seen limited success because it is much
more challenging to maintain RNA stability during the
microdissection process. Other drawbacks of LCM are that
such procedures are time-consuming and yield insuffi-
cient quantities of RNA, thus requiring multiple amplifi-
cation steps that may confound quantitative inferences
from gene expression data.
A recent paper by Ghosh [8] introduced a mixture model
based framework for determining differential expression
in the presence of mixed cell populations. In this study,
we aim at reconstructing the actual expression values of
the pure cell types from the heterogeneous mixtures. That
is, we develop a computational method for removing the
effect of mixing from heterogeneous samples and to
microdissect microarray data in silico. Similar analytical
approaches have been previously proposed by Lu et al. [9],
Stuart et al. [10] and Venet et al. [11]. Lu et al. focused on
estimating the fraction of cells in different phases of the
cell cycle whereas Stuart et al. considered the problem of
estimating the cell type specific expression patterns over
all samples. Here we focus on estimating both the sample
and cell type specific expression values using carefully
controlled microarray experiments. The inversion of the
'cell mixing effect' can be made appreciably easier by pro-
viding estimates of the mixing percentages of different cell
types in each measurement, which can be measured by an
experienced pathologist. The entire process does not
hinge upon such measurements, however, as the mixing
percentages can be estimated within the modeling frame-
work. Venet et al. [11] introduced some preliminary meth-
ods and results for tackling the same problem as we
consider here. In particular, they used a similar regression
based framework as in [10] and as we do. We also con-
sider the problem of selecting the correct number of cell
types using the cross-validation model selection
framework.
Results
The microarray data to which we apply our computational
methods consists of five different heterogeneous mixtures
of lymph node and colon cancer samples which are here-
after abbreviated as normal and RKO, respectively. For
more details, see Materials and methods Section. Each
Table 3: The measured mixing percentages. The measured mixing percentages (RKO/normal) in the five heterogeneous samples.
sample #1 sample #2 sample #3 sample #4 sample #5
RKO 100 80 56 30 0
n o r m a l 0 2 04 47 0 1 0 0BMC Bioinformatics 2005, 6:54 http://www.biomedcentral.com/1471-2105/6/54
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heterogeneous mixture consists of different fractions of
different cell samples, see Table 3.
Inversion of sample heterogeneity
The first goal is to invert the mixing effect caused by sam-
ple heterogeneity. We apply the linear model developed
in Materials and methods Section to the heterogeneous
microarray data. The obtained results are presented
below.
Because of the inherent variability of individual gene
expression values, the performance of the inversion
method cannot be estimated based on results for individ-
ual genes. (For illustration purposes, the results of inver-
sion of the mixing effect for individual genes are discussed
and shown later on in connection with Figures 6 and 7.)
Thus, we examine the performance of our method glo-
bally, by comparing the measured and estimated expres-
sion values of all the genes simultaneously. For
performance evaluation and visualization purposes, the
dimensionality of the 4704-dimensional expression pro-
files is reduced using the standard principal component
analysis (PCA). The effect of the sample heterogeneity is
the same for all the genes within one array. Therefore, for
each array, it is useful to combine the results over all the
genes. In other words, instead of looking at individual
genes, we combine the expression values of all the genes
and visualize the results using the most significant princi-
pal components. For comparison purposes, we also show
the samples used as a reference in the conducted microar-
ray experiments. Since the number of measurements is far
smaller than the number of genes, we use a standard
approach when solving the PCA eigenvector-eigenvalue
problem. Let   and  , i = 1,
..., K, denote the measured mixture and reference samples,
respectively, and let   and 
denote the estimated RKO and normal expression pro-
files. Let
,
where  . Instead of
finding the eigenvalues of the original sample covariance
matrix DTD, we compute them for the matrix DDT. The
eigenvalues of DTD and DDT are the same and the eigen-
vectors of DTD can be obtained from the eigenvectors of
DDT by multiplying them by DT. Results of the inversion
of the sample heterogeneity are shown in Figures 1 and 2.
In Figure 1, all five heterogeneous samples are used to esti-
mate the expression values of the pure colon cancer and
lymphocyte samples. The two most significant PCA com-
ponents of all the heterogeneous samples, reference sam-
ples, and the estimated expression profile of the pure
colon cancer cells and lymphocytes are shown. Figure 1
clearly shows that the heterogeneous samples ('m1'
through 'm5') are located almost on a straight line in the
2-dimensional PCA space. Furthermore, the line on which
the heterogeneous samples are lying is parallel to the first
principal component, suggesting that the most significant
variation in the data is due to the linear mixing effect. The
estimated expression profile of the pure colon cancer cells
and lymphocytes are close to samples number #1 and #5,
respectively, indicating that the inversion of the mixing
phenomenon produces reasonable results.
The results are more easily appreciated when only the
most significant PCA component is shown. As discussed
above, the variation in the most significant PCA compo-
nent is due to the mixing effect. The results in Figure 2 (a)
are as in Figure 1, but now shown in 1-dimension in order
to facilitate the interpretation. Results in Figure 2 (b), in
turn, are as in Figure 2 (a) except that the inversion was
done using only the samples #2, #3, and #4. This repre-
sents a more difficult and realistic case, since fewer mix-
tures are available.
When comparing Figure 2 (a) with Figure 2 (b), one can
conclude that the method performs slightly better when
more samples are used to estimate the true expression pro-
files – a result that was expected. Overall performance,
however, is good in both cases. The estimated expression
values for the pure colon cancer (RKO) are close to the
mixture #1, as it should be since the mixture #1 corre-
sponds to a measurement of the pure colon cancer. Simi-
larly, the estimated expression values of the pure
lymphocytes are close to the mixture #5 as well as to all of
the reference samples (note that samples used in the refer-
ence channel (Cy5) are the same lymphocytes as the ones
used in the mixtures). In Figure 1 and 2 (a), the most sig-
nificant PCA component and the two most significant
PCA components explain about 70.0% and 81.9% of the
total variation in the data, respectively. For the reduced
data, for which the results are shown in Figure 2 (b), a
slightly smaller fraction of the variance is explained,
namely about 67.3% and 81.2%. The results obviously
depend on the optimality criterion for which we used the
standard least squares. Less outlier sensitive results can be
obtained with robust regression methods, such as the
Huber estimator with the iteratively reweighted least
squares implementation [12,13] or median based regres-
sion methods [12,14]. The robust methods provided sim-
ilar global results, but improved results for some
individual genes that contained one or more outliers.
Optimization of mixing percentages
In practice, the true mixing percentages are not known but
must be measured by some means. Therefore, they are
also likely to contain some error. So, in addition to invert-
ing the mixing effect, it is also useful to simultaneously
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Results of the sample heterogeneity inversion in the 2-dimensional PCA space Figure 1
Results of the sample heterogeneity inversion in the 2-dimensional PCA space. All five heterogeneous samples are 
used to estimate the expression profiles of the pure colon cancer cells and lymphocytes. Symbols: estimated expression pro-
files of the pure colon cancer cells and lymphocytes (gray stars), mixture samples (green triangles), and reference samples (red 
circles). The labels next to each green triangle (resp. red circle) denote the number of the heterogeneous (resp. reference) 
sample, e.g., 'm1' = mixture sample #1 and 'r1' = reference sample #1, etc. (see also Table 3). The estimated expression profile 
of the pure colon cancer cells and lymphocytes have labels 'e1' and 'e5', respectively. See text for further details.
Results of the sample heterogeneity inversion in the 1-dimensional PCA space Figure 2
Results of the sample heterogeneity inversion in the 1-dimensional PCA space. (a) All five heterogeneous samples, 
and (b) only the heterogeneous samples #2, #3, and #4 are used to estimate the expression profiles of the pure colon cancer 
cells and lymphocytes. The height of each bar corresponds to the value of the most significant PCA component. Each bar cor-
responds to a heterogeneous sample, reference sample, or estimated expression profile and is labelled with the corresponding 
text.
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Estimated 90 % confidence intervals for the estimated expression values of the pure cell types Figure 6
Estimated 90 % confidence intervals for the estimated expression values of the pure cell types. The horizontal 
and vertical axes correspond to the fraction of lymph node cells and the normalized expression value, respectively. Symbols: 
the measured expression values (blue circles), the estimated expression values of the pure cell types (red stars), regression-
based confidence intervals (red points), and bootstrap-based confidence intervals (red x-marks).
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estimate the most likely value of the mixing percentages.
This problem can be formulated as type of optimization
problem, the details of which are shown in the Materials
and methods Section. The proposed optimization scheme
was applied to the heterogeneous microarray data. Since
the heterogeneous samples #1 and #5 correspond to the
cases where only colon cancer cells and lymph node cells
are used, respectively, we may assume that α 1 = 1 and α 5 =
Detecting differentially expressed genes Figure 7
Detecting differentially expressed genes. A set of genes which are not found to be significantly differentially expressed 
based on the heterogeneous measurements (samples #2 and #4, blue circles). After the inversion of the mixing effect, how-
ever, the expression difference between the estimated pure colon cancer cells and lymphocytes (red stars) meet even a more 
stringent criterion of differential expression. The horizontal and vertical axes correspond to the fraction of lymph node cells 
and the normalized expression value, respectively. Symbols: the heterogeneous samples (blue circles), the estimated expres-
sion values (red stars), and the measured expression values of the pure colon cancer cells (blue squares). See text for more 
details.
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0. Thus, we only estimate the value of the three remaining
mixing parameters. However, practically the same results
are obtained when all the five mixing parameters are esti-
mated. We found that the convergence of the above
method is practically independent of the initialization in
step 1. The convergence of the optimization method is
illustrated in Figure 3 by showing the evolution of the
value of the objective function. Parameters in Â(1) are ini-
tialized using the measured values shown in Table 3.
The found optimal values of the mixing percentages are
shown in Table 1. The values of the estimated mixing
parameters are in a good agreement with the results
shown in Figure 2. That is, for instance, the heterogeneous
sample #2 is quite close to the heterogeneous sample #1
(α 2 ≈  0.9296) and the heterogeneous sample #4 is fairly
far away from the heterogeneous sample #5 (α 4 ≈  0.3796).
Note that estimation of the mixing parameters may also
compensate for some other errors/biases in the data than
just the mixing percentages.
The obtained expression estimates for the pure colon can-
cer and lymph node samples, when all five heterogeneous
samples are used in estimation, are shown in Figure 4.
Again, the two most significant PCA components of all the
heterogeneous samples, reference samples, and the esti-
mated expression profiles of the pure colon cancer cells
and lymphocytes are shown. It is instructive to compare
these results with the ones shown in Figure 1. Because the
heterogeneous samples are again located almost on a
straight line, we use 1-dimensional visualization for the
results. Figure 5 shows the obtained expression estimates
in 1-dimensional PCA space.
Again, the estimated expression values for the pure colon
cancer cells (RKO) are close to those from mixture #1, as
it should be, since mixture #1 corresponds to a measure-
ment of the pure colon cancer cells. Similarly, the esti-
mated values from the lymph node sample are close to
those from mixture #5 as well as to all of the reference
samples. In Figures 4 and 5 (a), the first PCA component
Evolution of the value of the objective function Figure 3
Evolution of the value of the objective function. The red (resp. blue) graph corresponds to the value of the objective 
function after step 2 (resp. step 3).
Table 1: The estimated mixing percentages. The found optimal values of the mixing percentages.
sample #2 sample #3 sample #4
RKO 92.96 65.06 37.96
normal 7.04 34.94 62.04
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Results of the combined sample heterogeneity inversion and the estimation of the most likely values of the mixing parameters  in the 2-dimensional PCA space Figure 4
Results of the combined sample heterogeneity inversion and the estimation of the most likely values of the 
mixing parameters in the 2-dimensional PCA space. All five heterogeneous samples are used to estimate the expres-
sion profiles of the pure colon cancer and lymphocyte. Symbols: estimated expression profiles (gray stars), mixture samples 
(green triangles), and reference samples (red circles). See text for further details.
Results of the combined sample heterogeneity inversion and the estimation of the most likely values of the mixing parameters  in the 1-dimensional PCA space Figure 5
Results of the combined sample heterogeneity inversion and the estimation of the most likely values of the 
mixing parameters in the 1-dimensional PCA space. (a) All five heterogeneous samples, and (b) only the heterogeneous 
samples #2, #3, and #4 are used to estimate the expression profiles of the pure colon cancer cells and lymphocytes. Each bar 
corresponds to a heterogeneous sample, reference sample, or estimated expression profile and is labelled with the corre-
sponding text. The height of each bar corresponds to the value of the most significant PCA component.
−1.5 −1 −0.5 0 0.5 1
x 10
7
−4
−2
0
2
x 10
6
m1
r1
m2
r2
m3
r3
m4
r4
m5
r5
e1
e5
the 1
st principal component
t
h
e
 
2
n
d
 
p
r
i
n
c
i
p
a
l
 
c
o
m
p
o
n
e
n
t
−2.15e+007
−1.65e+007
−1.15e+007
−6.5e+006
−1.5e+006
3.5e+006
8.5e+006
1.35e+007
t
h
e
 
f
i
r
s
t
 
P
C
A
 
c
o
m
p
o
n
e
n
t
e
s
t
i
m
a
t
e
o
f
 
R
K
O
m
i
x
t
u
r
e
 
#
1
m
i
x
t
u
r
e
 
#
2
m
i
x
t
u
r
e
 
#
3
m
i
x
t
u
r
e
 
#
4
m
i
x
t
u
r
e
 
#
5
e
s
t
i
m
a
t
e
 
o
f
 
n
o
r
m
a
l
r
e
f
e
r
e
n
c
e
 
#
1
r
e
f
e
r
e
n
c
e
 
#
2
r
e
f
e
r
e
n
c
e
 
#
3
r
e
f
e
r
e
n
c
e
 
#
4
r
e
f
e
r
e
n
c
e
 
#
5
￿￿￿
−2.25e+007
−1.75e+007
−1.25e+007
−7.5e+006
−2.5e+006
2.5e+006
7.5e+006
1.25e+007
t
h
e
 
f
i
r
s
t
 
P
C
A
 
c
o
m
p
o
n
e
n
t
e
s
t
i
m
a
t
e
o
f
 
R
K
O
m
i
x
t
u
r
e
 
#
1
m
i
x
t
u
r
e
 
#
2
m
i
x
t
u
r
e
 
#
3
m
i
x
t
u
r
e
 
#
4
m
i
x
t
u
r
e
 
#
5
e
s
t
i
m
a
t
e
 
o
f
 
n
o
r
m
a
l
r
e
f
e
r
e
n
c
e
 
#
1
r
e
f
e
r
e
n
c
e
 
#
2
r
e
f
e
r
e
n
c
e
 
#
3
r
e
f
e
r
e
n
c
e
 
#
4
r
e
f
e
r
e
n
c
e
 
#
5
￿￿￿BMC Bioinformatics 2005, 6:54 http://www.biomedcentral.com/1471-2105/6/54
Page 9 of 15
(page number not for citation purposes)
and the first two PCA components explain about 69.2%
and 81.7% of the total variation in the data. For the
reduced data, for which the results are shown in Figure 5
(b), the fractions of variance explained are about 65.1%
and 80.4%. Although the fraction of variance explained is
slightly smaller than without the optimization of the
mixing parameters, the optimized mixing parameters pro-
vide a better fit to the data.
Confidence intervals
Above we were only interested in estimating the expres-
sion values of the pure cell types. Often it is also useful to
assess the confidence intervals of the obtained expression
estimates. For that purpose, we consider two methods:
one based on Gaussian approximation and the other
using bootstrap. (For more details, see Materials and
methods Section.)
For illustration purposes, Figure 6 shows the 90% esti-
mated confidence intervals for a set of genes by pooling
each of them with the 50 closest genes. The horizontal
and vertical axes correspond to the fraction of lymph node
cells and the normalized expression value, respectively. In
other words, the different heterogeneous mixtures are
placed on the x-axis according to the corresponding mix-
ing fractions. The vertical lines at x = 0 and x = 1 expand
over the maximum of the two confidence intervals. In
most of the cases the two confidence intervals are in good
agreement. The confidence intervals can be tightened by
measuring more heterogeneous mixtures.
The proposed inversion methods for the sample heteroge-
neity were also tested on standard non-replicated microar-
ray data by treating the replicated measurements for each
gene as individual "genes." The obtained results were
qualitatively similar with the ones shown above and only
slightly more variable. In a similar fashion, we examined
the effect of low quality replicates on the heterogeneity
inversion. Slightly less variable results were obtained with
a method [15] that detects and removes unreliable repli-
cates prior to the averaging. A drawback of such unreliable
spot detection is that, without any missing value estima-
tion method, some of the genes will be excluded from fur-
ther analysis.
Selection of the number of cell types
It is known that the heterogeneous mixtures used in our
experiments consist of only two cell types. However, in
general case, heterogeneous mixtures may contain an
unknown number of cell types. In those cases, it is useful
to assess the validity of the model (i.e., the number of cell
types) as well. As introduced in Materials and methods
Section, the linear mixing model can be extended to incor-
porate more than just two cell types. We use a general pur-
pose cross-validation for model selection. In particular,
we apply the so-called leave-one-out cross-validation
(LOOCV) and test the one, two, and three cell type mod-
els. (For more computational details, see Materials and
methods Section.)
For the three cell type model, the number of samples does
not permit us to optimize the mixing percentages for each
cross-validation training data set separately. Therefore,
within the cross-validation loop, we use fixed mixing
percentages and only estimate the expression values. For
the two and three cell type models we use the estimated
mixing percentages shown in Tables 1 and 2, respectively.
The relative LOOCV errors for the one, two, and three cell
type models are 1.79, 1.00, and 2.28, respectively. The
results suggest that the two cell type model is indeed the
correct one.
Discussion
This paper presents an inversion method for the effects of
sample heterogeneity. The proposed method is success-
fully applied to a carefully controlled microarray data con-
sisting of five different heterogeneous mixtures of lymph
node and colon cancer samples. The results demonstrate
that both the sample and cell type specific expression val-
ues can be reconstructed from heterogeneous mixtures. In
some situations, such as cancer metastases in the lymph
node, lymphocytes constitute a major cell type beside
tumors. Hence, with careful sample preparation, the two
cell type model can directly be applied to such cases. For
unknown heterogeneous mixtures obtained from more
complex cancer samples, the analysis may be a bit more
difficult. For example, contaminating cells may include
several cell types, such as fibroblasts, endothelial cells,
macrophages and lymphocytes. As the proposed method
Table 2: The estimated mixing percentages for the three cell type model. The found optimal values of the mixing percentages for the 
three cell type model.
cell type sample #1 sample #2 sample #3 sample #4 sample #5
RKO 98.15 67.94 58.70 30.74 0
normal 1.22 16.39 36.53 62.97 96.95
the 3rd cell type 0.63 15.66 4.77 6.29 3.05BMC Bioinformatics 2005, 6:54 http://www.biomedcentral.com/1471-2105/6/54
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can be applied to any cell types and to any number of cell
types, the method works in principle in more complex
cases as well. Requirement for the number of measure-
ments necessary for reliable inversion, however, increases
together with the number of cell types present in the
sample.
We have emphasized that proper inversion of the mixing
effect results in more accurate expression values of the
pure cell types. While this is true, it must be noted that
clinically relevant information may also be incorporated
into other populations than the pure (cancer) cells. For
example, the degree of lymphocyte infiltration may be
clinically important and could be used to complement
microarray analysis. However, for comparative microarray
analysis, it is important to make comparisons between
homogeneous samples so as to minimize the confound-
ing influence of different proportions of contaminating
cell types.
Application of 'in silico microdissection' to detection of 
differentially expressed genes
In order to illustrate the above 'in silico microdissection'
in practice, consider the following (hypothetical) experi-
mental setting. Given the three middle mixture measure-
ments (#2, #3, and #4), a goal is to identify a set of genes
which are differentially expressed between the colon can-
cer and the lymph node samples. In a simple approach,
often used in practice, the most heterogeneous sample
would be discarded since it is measured to contain about
56% (resp., 44%) of colon cancer cells (resp., lym-
phocytes), thus giving no direct discriminative informa-
tion about the underlying two samples. For illustration
purposes, let us measure the expression difference of a
given gene between these two samples using the fold-
change, i.e., the expression value of the ith gene in the
colon cancer sample,  , is regarded as being differen-
tially over-expressed (resp., under-expressed) if the ratio
of   to the expression value of the same gene in the
lymph node sample,  , is at least 2 (resp., smaller than
1/2). Of course, in practice, more sophisticated methods
for detecting differential expression, including correction
for multiple testing, should be used. However, for illustra-
tive purposes, this example will suffice. Since only the het-
erogeneous samples are available, without any inversion
of the mixing effect, one must compare the mixture meas-
urement   and  . Figure 7 shows some example genes
whose expression difference (i.e., the fold-change)
between the two heterogeneous samples is within the
given threshold (above 1/2 and below 2), but after the 'in
silico microdissection,' the expression difference exceeds
even a more stringent criterion (approximately 4-fold-
change). The measured mixing percentages are used in the
estimation (see Table 3). It is clear from this example that
the proposed method is able to correctly detect differen-
tial expression even from heterogeneous samples, espe-
cially when the direct use of such samples may fail to find
differential expression. Indeed, the conclusions we can
draw based on the red stars are consistent with those that
are based on the true homogeneous samples represented
by blue squares in Figure 7.
As is evident from the example above, heterogeneity in the
biological sample preparation can hinder further statisti-
cal analysis steps. Not only can the heterogeneity blur the
identification of differentially expressed genes, it can also
cause contrary effects. Presence of a considerable percent-
age of additional cell types can result in the identification
of differentially expressed genes that may be unrelated to
the biological question being studied. Similarly, irrelevant
gene combinations can be discovered in the case of gene
expression based classification. For an illustration, see
[16] where the authors analyzed a colon cancer data set
contaminated with muscle cells.
Although the microarray technology has been improved
during the recent years, the measurements are still moder-
ately noisy. The easiest and the most widely used
approach for improving the measurement quality is to
capture replicated measurements. This may become costly
because each additional measurement requires an extra
spot on the array, or an extra array. An alternative
approach based on so-called composite microarrays was
introduced in [17], where several different oligos repre-
senting different genes are printed on each spot. The
multiplexing results in a mixing effect similar to the one
introduced in this manuscript, and the phenomenon can
be inverted to get the reconstructed expression values for
single genes. The benefit is to obtain more replicated
measurements without proportionately increasing the
number of printed spots. Closely related ideas have also
been introduced from an error-correcting microarray
design point of view in [18]. The standard non-repeated
microarray method does not tolerate "drop-outs": if a spot
is badly corrupted and its intensity cannot be read, the
expression value of the corresponding gene will be
missed. Khan et al. showed that a certain amount of
"drop-outs" can be recovered from the multiplexed sam-
ples, thus providing more error-resilient measurements.
Following the methods developed in [17,18], instead of
multiplexing individual genes on spots, one may wish to
multiplex different samples on arrays, thus allowing a
fault-tolerant recovery of expression values in the case of
corrupted array(s). As a future extension, one can also
consider multiplexing both the genes on spots and the
samples on arrays. Similar methods for inverting the sam-
ple heterogeneity have also been studied in the context of
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time-series gene expression measurements in [19,20],
where the fundamental mixing effect is not due to the dif-
ferent tissue types present in the sample, but due to the
loss of synchrony of the cell population. It would be
worthwhile to simultaneously study the sample heteroge-
neity and the loss of synchrony in the future.
Conclusion
In this paper, we proposed a computational framework
for removing the effects of sample heterogeneity. In
addition to providing estimates of the expression values
of the pure (non-heterogeneous) cell samples, the pro-
posed computational methods can also be used to esti-
mate the mixing percentages of different cell types.
Furthermore, we also proposed a way of applying general-
purpose model selection method for the selection of the
correct number of cell types. Application of the proposed
methods to a carefully controlled cDNA microarray data
obtained from heterogeneous samples shows that the
computational methods can invert the effect of sample
heterogeneity and, at the same time, estimate the mixing
percentages of the different cell types. Furthermore, a gen-
eral purpose model selection method can be used to select
the correct number of cell types.
Materials and methods
Microarray production
RNA isolation, microarray production, and microarray
hybridization were carried out as described previously in
[21]. RNA from normal human lymph node was pur-
chased from a commercial source (Stratagene, La Jolla,
CA). Five µg aliquots of total RNA from normal lymph
node and RKO colon cancer cell line were reverse tran-
scribed using Superscript II RT (Invitrogen, Carlsbad, CA)
in conjunction with oligodT-T7 primers according to the
manufacturer's suggested protocol. The second strand was
synthesized using 10U E. coli DNA ligase (vendor), 40U E.
coli DNA polymerase I (vendor), and 2U E. coli Rnase H
(vendor). This reaction was stopped with EDTA and then
cleaned with Qiagen's PCR Purification kit (Qiagen,
Valencia, CA). The double stranded cDNA was then
amplified by an in vitro transcription reaction (Ambion,
Austin, TX) and cleaned with Qiagen's Rneasy kit (Qiagen,
Valencia, CA). Each amplified cRNA sample was then
quantitated using a Beckman DU640 spectrophotometer
(Beckman, Fullerton, CA). Five µg amplified cRNA from
Stratagene's normal lymph node was labeled with Cy5 for
each microarray hybridization. Mixtures of appropriate
volumes of cRNA from normal lymph node and RKO
were labeled with Cy3 in a reverse transcription reaction
using Superscript II RT (see Table 3). Labeled samples
were co-hybridized overnight at 60°C in a humidified
incubator on a cDNA microarray containing 4704 human
genes in duplicate produced in-house. The 4704 genes
represent most of the known genes in the cDNA library we
used to generate the microarrays. For the purpose of this
study, the identity of the genes is not very important since
we only study the general effect of sample heterogeneity.
As the mixing effect is the same for all the genes, we expect
to have similar results when the whole genome arrays are
used. Slides were scanned with an LS-IV laser scanner
(Genomic Solutions, Ann Arbor, MI). In total, five differ-
ent heterogeneous mixtures were measured. The meas-
ured mixing percentages are shown in Table 3.
Preprocessing
The microarray data consists of five different heterogene-
ous mixtures of lymph node and colon cancer samples
which are hereafter abbreviated as normal and RKO,
respectively. (For more details, see Microarray production
Section above and Table 3.) The gene expression data set
was preprocessed as follows. The replicated background-
subtracted signal intensities were averaged and log2-trans-
formed, and the dye-bias effect was corrected in the log2-
domain using the standard lowess smoothing-based nor-
malization (see e.g. [22]) with smoothing parameter f =
0.7. Because the averaging effect (source of heterogeneity)
takes place on the molecular level, the phenomenon must
be modeled using the absolute expression values. There-
fore, after the correction of the dye-bias, the data were
transformed back to the original domain using the inverse
of the log2-transformation. Correspondingly, single-chan-
nel data were used for further analysis. In order to mitigate
the between array variability, the data were further stand-
ardized for each array and the two channels separately.
Modeling sample heterogeneity
The two samples, RKO colon cancer cells and normal lym-
phocytes, are mixed at the extracted RNA level. Therefore,
without any further verification, the model can be
assumed to be linear. Lymphocytes were used because
tumor tissues often contain infiltrating lymphocytes,
especially in tumor metastases in the lymph nodes. Let 
and   denote the expression level of the ith gene in the
colon cancer (RKO) and in the lymph node (normal)
samples, respectively. Assuming only two different cell
types are mixed, the sample heterogeneity is modeled by
a simple linear model
where   denotes the expression value of the ith gene in
the kth heterogeneous sample, and 0 ≤  α k ≤  1 denotes the
fraction of the colon cancer cells in the kth mixture. It is
worth noting that we use the same mathematical model
for the sample heterogeneity as in [9-11]. Also note that in
Equation (1) it is assumed that the expression level in
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RKO ( ) and normal ( ) is "fixed" and does not change
between heterogeneous measurements. In other words,
the measurements   come from the same heterogeneous
sample with different mixing fractions. In order to allow
variation in the expression values between different
samples/treatments/time points, the same model can be
applied separately to each set of measurements from the
other samples/treatments/time points. The same model
can also be extended to more than two cell types (for more
details, see Selection of the number of cell types Section
below).
Inversion of sample heterogeneity
The first objective is to invert the mixing effect shown in
Equation (1), that is, to obtain estimates for the expres-
sion values of the pure colon cancer cells and the pure
lymphocytes. In practice, however, the measured expres-
sion values, yi, include one or more sources of noise. By
making some distributional assumptions, one could use
standard model-based estimation methods. However, in
order to avoid making additional modeling assumptions,
we prefer to use a general purpose least squares method to
estimate the gene expression levels corresponding to the
pure samples.
Let the number of genes be n and assume that one has
measured the expression values for K different heteroge-
neous mixtures. Thus, one has measurements  , 1 ≤  i ≤
n, 1 ≤  k ≤  K. Let us also assume for now that the mixing
percentages are known or have been measured. For the ith
gene the sample heterogeneity can be expressed as
(excluding all noise terms)
When including all n  genes, the above model can be
rewritten as
where 0 denotes the K-by-2 zero matrix. Let the block
matrix in Equation (2) above be denoted as Ã Assuming
the column rank of A is full, the well-known least squares
solution is given by
where  . Due to the structure of the
matrix Ã, the least squares solution can be obtained gene-
wise as  .
The Gauss-Markov theorem says that the standard least
squares solution is indeed the best linear unbiased esti-
mate if the noise in the measurements is additive and i.i.d.
with constant variance. However, a common observation
is that the homoscedasticity does not always hold for
microarray data, but instead, the noise variance depends
on the underlying signal intensity [23,24]. Such hetero-
scedasticity may decrease the power of the inversion
method shown in Equation (3). Fortunately, the structure
of the matrix Ã ensures that the inversion can also be per-
formed for each gene separately. Consequently, it is not
necessary for the homoscedasticity to hold globally.
Indeed, all we need to assume is that the noise variance is
approximately constant for each gene separately.
Also note that, in this two cell type model, no prior
knowledge about the expression values of either of the
two cell types is needed since the method estimates the
expression values for both of the two cell types. The same
is also true for more general models including more cell
types, assuming the model is sufficiently over-determined
(see also Selection of the number of cell types Section
below).
Optimization of mixing percentages
In practice, the mixing percentages must be measured by
some means. Therefore, they are also likely to contain
some error. So, overall, one would like to estimate not
only the expression values for the pure cell types but also
the most likely value of the mixing percentages.
Assuming the model in Equation (2) is sufficiently over-
determined, the mixing parameters can be adjusted com-
putationally, too. Let us again consider the case where
only two different cell types are mixed. Note that K
denotes the number of different heterogeneous mixtures
measured. Therefore, the regression matrix Ã in Equation
(2) has only K  free parameters. Since the number of
expression values to be estimated is 2n, the total number
of free parameters in Equation (2) is 2n + K. The number
of equations in Equation (2) is Kn. Hence, the model is
over-determined if Kn > 2n + K, which, for a fixed n ≥  3,
holds if K > 2. (Note that in our case we have measured
five different heterogeneous mixtures, i.e., K  = 5.) As
above, no assumptions on the noise distributions are
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being made and we use the least squares method. This
results in the following optimization problem
A similar optimization problem was also introduced in
[11].
Because the objective function in Equation (4) above is
minimized over both Ã and x, the objective function is
not linear in the parameters anymore and, therefore, can-
not be solved as in Equation (3). In general, any iterative
optimization method can be used to get a solution. Itera-
tive methods usually become inefficient/unstable as the
number of parameters to be optimized increases. In this
case, the number of free parameters in Ã and x is 2n + K.
Therefore, we use a two-step approach in the optimiza-
tion. In the first step, given proper initial value for Ã, the
least squares solution for x is found using Equation (3). In
the second step, the mixing percentages are optimized in
the least squares sense (subject to the constraints 0 ≤  α k ≤
1 for all 1 ≤  k ≤  K) using the previously found value for x.
These two steps are then repeated, essentially resulting in
a type of expectation-maximization (EM) approach. A
similar iterative procedure was also proposed in [11],
except with different constraints. Note that when Equa-
tion (4) is minimized over Ã, given the value of x, the opti-
mization problem is again linear in its parameters.
Assuming the constraints are not violated, the standard
equation (similar to the one in Equation (3)) can be
applied. If that is not the case, then any general-purpose
constrained optimization method may be applied. Let
 (resp. Â(j)) denote the value of x (resp. Ã) after the jth
iteration. Details of the algorithm are shown in Figure 8.
Clearly, at each iteration of steps 2 and 3, the value of the
objective function is decreased. Thus, a minimum will be
found.
Confidence intervals
It is useful to assess the confidence intervals of the
obtained expression estimates. As explained above, the
Gauss-Markov theorem is applied gene-wise that greatly
alleviates the issue of heteroscedasticity. Should the noise
variance σ 2 be constant, then the variance of the estimated
expression values would be  . Due to
the special structure of the matrix Ã (i.e., the gene-wise
inversion of the mixing effect), the variance of the
estimated expression values for the ith gene can be
expressed as
where   is the noise variance for the ith gene. A straight-
forward way of obtaining an estimate of the variance is to
compute the sample noise variance   for each gene and
then apply Equation (5) to get  . That would result in
somewhat sensitive variance estimates since there are only
K = 5 error residuals associated with each gene. A better
alternative is to pool genes which have approximately the
The two-step optimization algorithm Figure 8
The two-step optimization algorithm. Details of the two-step algorithm used for the optimization problem shown in 
Equation (4).
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same average expression value   and then
compute the sample noise variance from the error residu-
als of the pooled genes. Although we do not assume Gaus-
sian noise distribution, we can resort to the Gaussian
approximation when computing the confidence intervals.
For example, using the Gaussian approximation, the 1 -
2α  confidence interval for estimated expression value of
the  ith gene in the colon cancer cells is
, where Φ -1(·) is the inverse of the standard normal cumu-
lative distribution function and   denotes the
(1,1) element of the estimated variance matrix 
(similarly for the lymph node sample:
). Alternatively, the confidence intervals can be obtained
using the non-parametric bootstrap framework [25]. Here
we consider the method in which one re-samples the error
residuals with replacement (within the set of pooled
genes) and computes the confidence intervals directly
from the α  and 1 - α  percentiles of the bootstrap distribu-
tion of the expression estimates.
Selection of the number of cell types
Although it is known that only two cell types are mixed in
our experiments there may be other experimental settings
where the number of cell types may be unknown. Then it
is useful to assess the validity of the model as well. As was
mentioned above, the linear mixing model can be
extended to incorporate more than just two cell types
using a straightforward extension:  , where
 denotes the expression value of the ith gene in the jth
cell type, and 0 ≤    ≤  1 denotes the fraction of the jth cell
type in the kth mixture. The mixing percentages must also
satisfy   for  all  k. The significance of different
'regression coefficients'   could be tested using standard
regression-based statistical tests. Since those tests apply
only to Gaussian noise we recommend using a general
purpose cross-validation for model selection (see e.g.
[26]). Here we consider the leave-one-out cross-validation
(LOOCV) and test the one, two, and three cell type mod-
els. Thus, each heterogeneous sample is left out from the
training data at a time, the regression coefficients are esti-
mated based on the remaining four samples, and the
model is then tested on the sample which was left out
from the training data set.
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